TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview) May 16, 2003
TCL Archive Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin July 27, 2012
